Large-scale manufacturing process for Strangvac now secured

Tuesday April 2nd, 2019 | General

We are so glad to be part of such an exciting project with the Swedish company INTERVACC, who we are working with on manufacturing of Strangvac® including the large-scale production of the vaccine against equine strangles. The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, secured large-scale production of the […]

3P Biopharmaceuticals enters into a new manufacturing agreement with the Dutch Biotech Company Xenikos

Monday March 11th, 2019 | General

Pamplona, 11th of March, 2019. 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Dutch biotech company Xenikos B. V. (Xenikos) that will cover the global manufacturing of Xenikos’ proprietary lead product candidate T-Guard®. 3P and Xenikos started their collaboration in 2015 […]

Expansion of analytical capacities by 3P Biopharmaceuticals

Wednesday February 27th, 2019 | General

3P Biopharmaceuticals has recently increased its analytical capacities and capabilities.   The 3P Analytical Development Area is one of the company’s core competences and is crucial to the state-of-the-art technologies as well as services it provides to the clients.   The development of analytical methods is an essential activity in any process development and manufacturing […]


Wednesday February 13th, 2019 | Events

Meet us at the largest springtime biotech partnering event! Our team will be attending one more time this international event. Meet us at booth #47 and learn more about our solutions for your biologics manufacturing!

Biologics World Nordic 2019

Wednesday February 6th, 2019 | Events

Our team will be attending the very next Biologics World Nordic! Biologics World Nordic is the only focused biologic drugs and vaccines conference in the Nordic region. Contact now Marina Santos to schedule a meeting!